VESICARE
Astellas Pharma Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75932952 |
| Registration Number | 2535639 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Domestic Representative | Richard M. Goldberg |
| Attorney Name | Daniel M. Gurfinkel |
| Attorney Docket Number | 30115-100660 |
| Law Office Assigned | M60 |
| Employee Name | SOUDERS, MICHAEL J |
Timeline
| 2000-03-02 | Application Filed |
| 2001-11-13 | Published for Opposition |
| 2002-02-05 | Trademark Registered |
| 2012-02-05 | Renewal Date |
| 2012-03-05 | Location: GENERIC WEB UPDATE |
| 2012-03-05 | Status: Live/Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  ASTELLAS PHARMA INC. |
| Address | 3-11, NIHONBASHI-HONCHO 2-CHOME CHUO-KU, TOKYO JP |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations relating to the muscarinic M3 antagonist for the treatment of urge incontinence |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2000-08-03 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 2000-08-07 | 2 CNRT F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2000-09-11 | 3 CRFA I:Incoming Correspondence |
| LETTER OF SUSPENSION MAILED | 2001-02-01 | 4 CNSL F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-03-01 | 5 CRFA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-05-04 | 6 CRFA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2001-06-20 | 7 CNSA O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2001-10-24 | 8 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2001-11-13 | 9 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2002-02-05 | 10 R.PR A:Allowance for Publication |
| CASE FILE IN TICRS | 2007-04-03 | 11 CFIT O:Outgoing Correspondence |
| TEAS SECTION 8 RECEIVED | 2008-01-22 | 12 ES8R I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2008-01-25 | 13 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED | 2008-02-11 | 14 8.OK O:Outgoing Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2012-02-03 | 15 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2012-03-05 | 16 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2012-03-05 | 17 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2012-03-05 | 18 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2012-03-05 | 19 NA89 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2021-02-05 | 20 REM2 E:E-Mail |
| TEAS SECTION 15 RECEIVED | 2021-11-11 | 21 E15R I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2021-11-11 | 22 E89R I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-11-19 | 23 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-11-19 | 24 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-11-19 | 25 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-11-19 | 26 TCCA I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-06-03 | 27 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-06-03 | 28 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-06-03 | 29 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-06-03 | 30 TCCA I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-10-28 | 31 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2022-11-09 | 32 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | 2022-11-09 | 33 RNL2 Q: |
| REGISTERED - SEC. 15 ACKNOWLEDGED | 2022-11-09 | 34 15AK O:Outgoing Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-11-09 | 35 APRE A:Allowance for Publication |
| SEC. 15 ACKNOWLEDGEMENT - E-MAILED | 2022-11-09 | 36 NA15 E:E-Mail |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2022-11-09 | 37 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VESICARE 88833757 not registered Live/Pending |
Astellas Pharma Inc. 2020-03-13 |
 VESICARE 75932952 2535639 Live/Registered |
ASTELLAS PHARMA INC. 2000-03-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 